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Abstract
Background: Nerve terminal invasion by an axonal spike activates voltage-gated channels, triggering calcium entry, vesicle
fusion, and release of neurotransmitter. Ion channels activated at the terminal shape the presynaptic spike and so regulate
the magnitude and duration of calcium entry. Consequently characterization of the functional properties of ion channels at
nerve terminals is crucial to understand the regulation of transmitter release. Direct recordings from small neocortical nerve
terminals have revealed that external [Ca
2+] ([Ca
2+]o) indirectly regulates a non-selective cation channel (NSCC) in
neocortical nerve terminals via an unknown [Ca
2+]o sensor. Here, we identify the first component in a presynaptic calcium
signaling pathway.
Methodology/Principal Findings: By combining genetic and pharmacological approaches with direct patch-clamp
recordings from small acutely isolated neocortical nerve terminals we identify the extracellular calcium sensor. Our results
show that the calcium-sensing receptor (CaSR), a previously identified G-protein coupled receptor that is the mainstay in
serum calcium homeostasis, is the extracellular calcium sensor in these acutely dissociated nerve terminals. The NSCC
currents from reduced function mutant CaSR mice were less sensitive to changes in [Ca
2+]o than wild-type. Calindol, an
allosteric CaSR agonist, reduced NSCC currents in direct terminal recordings in a dose-dependent and reversible manner. In
contrast, glutamate and GABA did not affect the NSCC currents.
Conclusions/Significance: Our experiments identify CaSR as the first component in the [Ca
2+]o sensor-NSCC signaling
pathway in neocortical terminals. Decreases in [Ca
2+]o will depress synaptic transmission because of the exquisite sensitivity
of transmitter release to [Ca
2+]o following its entry via voltage-activated Ca
2+ channels. CaSR may detects such falls in [Ca
2+]o
and increase action potential duration by increasing NSCC activity, thereby attenuating the impact of decreases in [Ca
2+]o
on release probability. CaSR is positioned to detect the dynamic changes of [Ca
2+]o and provide presynaptic feedback that
will alter brain excitability.
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Introduction
Neurotransmitter release from nerve terminals underlies
synaptic communication in the brain. Invasion of the nerve
terminal by an axonal spike activates voltage-gated channels,
triggering calcium entry and exocytosis of transmitter-containing
vesicles [1]. Release probability at a given synapse is dynamic; the
ion channels activated at the terminal shape the presynaptic spike
and so regulate the magnitude and duration of calcium entry
[2,3,4]. Characterization of the functional properties of ion
channels at nerve terminals is thus crucial to understand
presynaptic regulation of transmitter release. Extension of patch
clamp techniques to small, relatively inaccessible nerve terminals
has substantially increased our understanding of presynaptic
function at these important sites [4,5]. One unexpected finding
is that external [Ca
2+] ([Ca
2+]o) indirectly regulates a non-selective
cation channel (NSCC) in the vast majority of neocortical nerve
terminals via an unknown [Ca
2+]o sensor [6]. However the
mechanism by which [Ca
2+]o exerts these effects is poorly
understood. Recent studies have underlined the central role in
regulation of neurotransmission of a number of calcium signaling
pathways [1,7]. While synchronous, asynchronous and spontane-
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extracellular Ca
2+ [7,8,9] these effects are usually attributed to
Ca
2+ entry via voltage-activated Ca
2+ channels (VACC) and less
attention has been focused on the presynaptic role of other Ca
2+
signaling pathways, such as surface charge screening [10,11,12] or
Ca
2+-dependent ion channels [6,13,14]. Attention is returning to
these other pathways with the realization that their influence may
have been underappreciated because supraphysiological [Ca
2+]o
employed in most studies ensured maximal receptor activation and
decreased the impact of physiological decreases in external [Ca
2+].
In this study we identify the receptor activating a novel calcium
signaling pathway using direct patch clamp recordings from nerve
terminals. Candidate [Ca
2+]o receptors include the extracellular
calcium-sensing receptor (CaSR), metabotropic glutamate recep-
tor (mGluR) and c-aminobutyric acid B receptor (GABABR). All
of these receptors have been identified as sensitive to [Ca
2+]o
[15,16,17,18], have been localized to the synapses of central
neurons [19,20,21,22,23], and have been classified as members of
G-protein coupled receptor (GPCR) family C [24]. In addition,
CaSR may heterodimerize with mGluR and GABABR [25,26,27],
raising the possibility that heterodimers involving some or all of
these GPCRs may modulate NSCC currents in nerve terminals.
Our experiments, studying the impact of CaSR agonists and a
CaSR mutation on the [Ca
2+]o sensor-NSCC pathway in nerve
terminals, show that the calcium-sensing receptor (CaSR), the
mainstay in serum calcium homeostasis, is the extracellular
calcium sensor regulating NSCC activity in neocortical nerve
terminals. In contrast, nerve terminals were insensitive to
glutamate and GABA arguing strongly against the mGluR and
the GABABR mediating these effects. This approach provides
insight into a novel pathway through which [Ca
2+]o influences
nerve terminal excitability.
Results
CaSR Mutation Reduces Affinity of [Ca
2+]o Detector
Small, acutely isolated neocortical nerve terminals sense [Ca
2+]o
and indirectly modulate a NSCC current (Figure 1A) as reported
previously [6,28]. The CaSR
2/2 mutant mouse lacks CaSR exon
5 which results in a reduced affinity for Ca
2+ [29]. However,
CaSR
2/2 mutant mice die prematurely and exhibit delayed
growth, preventing the preparation of synaptosomes from these
animals. We therefore used the heterozygous mouse (CaSR
+/2),
which has an elevated serum [Ca
2+] reflecting lower affinity for
[Ca
2+]o but normal growth and survival [30], to examine if the
CaSR mutation impacts nerve terminal sensitivity to [Ca
2+]o.I n
cell-attached recordings, 71 of 76 mouse neocortical nerve
terminals (93%) possessed the characteristic [Ca
2+]o-modulated
outward current. Outward NSCC currents were activated by
depolarization from 240 mV to 110 mV (all voltages were
relative to the resting membrane potential) while [Ca
2+]o was
changed between 6 mM and 60 mM (Figure 1A,B). Outward
currents were larger at lower [Ca
2+]o. The CaSR
+/2 terminals
were less sensitive to increases in [Ca
2+]o as illustrated by the traces
activated with 0.6 and 6 mM Ca
2+ in the bath solution (Figure 1A–
C). The activation kinetics (Figure 1A,B) were similar for CaSR
+/+
and CaSR
+/2 terminals. The concentration-effect relationship for
the normalized NSCC current amplitudes (Figure 1D) confirmed
that CaSR
+/2 terminals had a lower affinity than the CaSR
+/+
terminals (IC50 1.660.2 mM versus 1.160.07 mM respectively;
ANOVA, p=0.032). We measured the NSCC current amplitudes
elicited by 6 mM and 60 mM bath Ca
2+ to test if the maximum
and minimum currents respectively were also dependent on
genotype. However, CaSR
+/+ and CaSR
+/2 terminals had similar
maximum (2065 pA, n=16 vs 1764 pA, n=13; p=0.61) and
minimum currents (24.563.5 pA, n=7 vs 23.362.1 pA;
p=0.79) indicating the IC50, but not NSCC current amplitude
was dependent on the CaSR genotype. The reduction in affinity
for [Ca
2+]o in CaSR+/2 terminals was consistent with CaSR
involvement in modulation of the NSCC currents. The relatively
modest shift in affinity is similar to the changes observed following
heterologous co-expression of normal and other mutant CaSR
[31].
CaSR Is Present in Nerve Terminals
We next tested that CaSR was present in neocortical nerve
terminals using immunochemical techniques. CaSR was present in
rat whole brain tissue and synaptosomes by immunoblotting.
Western blots detected 140 and 160 kDa bands in HEK cells
transfected with CaSR (Figure 2A, left lane). These have been
shown to represent differentially glycosylated forms [29] and were
absent in untransfected control cells (Figure 2A, second lane).
Synaptosomes and whole brain (Figure 2A, third and fourth lanes,
respectively) contained the 160 kDa band and a lower band at
90 kDa, both of which were absent in control experiments
following preincubation with the specific antigenic peptide
fragment (data not shown). The 90 kDa band which has been
reported by others was also blocked by peptide fragment and
appears to be due to CaSR degradation [32]. To confirm CaSR
was present in nerve terminals we used a polyclonal antibody
raised against CaSR (4641; Figure 2C) and co-stained synapto-
somes with an antibody to synaptophysin (Figure 2B). Both
antibodies gave similar punctate patterns of staining that co-
localized (Figure 2D) indicating that CaSR is indeed present in
neocortical nerve terminals. The polyclonal antibody 4641 also
identified the 140 and 160 kDa bands in Western blots consistent
with a specific action (data not shown).
The Nerve Terminal [Ca
2+]o Sensor Is Modulated by
Allosteric CaSR Agonists
CaSR agonists including Ca
2+,M g
2+, spermidine, gadolinium,
and neomycin have been shown to modulate NSCC currents in
nerve terminals [6,33]. However, since these CaSR agonists also
interact with other targets [34], we employed more specific
pharmacological interventions against CaSR to explore the
identity of [Ca
2+]o-modulated NSCC. Allosteric CaSR agonists
bind to a transmembrane pocket of CaSR [35,36]. We tested if the
[Ca
2+]o-modulated NSCC currents in rat synaptosomes were
sensitive to Calindol, an allosteric CaSR agonist [37]. Out of 290
cell-attached recordings from rat neocortical nerve terminals, 230
(79%) possessed the characteristic [Ca
2+]o-modulated outward
current. In the cell-attached configuration, NSCC currents
activated by depolarization with a [Ca
2+]o of 60 mM were
substantially and reversibly inhibited by bath application of
10 mM Calindol (Figure 3A). Control experiments showed that
the solvent (ethanol) had no effect on the NSCC current amplitude
at 0.1% (Figure S1). Calindol acted in an apparently allosteric
fashion shifting the concentration-effect relationship for [Ca
2+]o to
the left. The average data from 11 recordings (Figure 3B) revealed
a decrease in slope as well as a left-shift with 2 mM Calindol. To
test whether the effect of Calindol was reduced in the presence of
very low [Ca
2+] as expected for an allosteric agonist, we reduced
the bath [Ca
2+] to nominally 0.2 mM and patch pipette solution
[Ca
2+] and [Mg
2+] from 2 mM to 100 mM. Under these
conditions, Calindol did not affect the NSCC currents
(Figure 3C; control versus test: 4.562.4 pA versus 4.562.6 pA
control versus; p.0.05, n=4). These findings indicate that
Calindol modulation of the [Ca
2+]o-modulated NSCC signaling
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PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8563Figure 2. CaSR is present in nerve terminals of neocortex. A, immunoblot of synaptosomes and whole brain show 160 kDa bands with anti-
CaSR antibody [76]. Positive control (HEK CaR) shows 140 and 160 kDa bands (glycosylated and unglycosylated forms) in CaSR- transfected HEK cells
and no signal in untransfected HEK cells (HEK Con). B, acutely isolated nerve terminals (synaptosomes) identified using the synaptophysin antibody
(red). C, CaSR identified with polyclonal antibody ‘‘4641’’ (green). D, superimposition of B and C shows that CaSR and synaptophysin are co-localized.
doi:10.1371/journal.pone.0008563.g002
Figure 1. Loss of function CaSR mutation reduces NSCC current sensitivity to [Ca
2+]o. Cell- attached recordings were made from (A) CaSR
+/+
and (B) CaSR
+/2 terminals and the Ca
2+ in the bath solution applied to terminals varied between 6 mM and 60 mM as indicated. Step depolarizations
(240to110 mVrelativetorestingmembranepotential)weremadeevery5seconds.Averagecurrenttraces(n=8215)areshownforeachbath[Ca
2+]at
steady-state for two exemplar recordings. Note that outward currents elicited with 0.6 and 6 mM Ca
2+ were proportionately larger in the heterozygote
than in the wild-type recording. C) timecourse of NSCC current amplitude (measured at the end of the depolarizing step) in the same CaSR
+/+ (filled
circles, left axis) and CaSR
+/2 (open circles, right axis) terminals as bath [Ca
2+] was increased (upper trace). Steady state amplitude was reached in 5–10 s
for both CaSR
+/+ and CaSR
+/2 genotypes. Axes were scaled to span the current amplitudes measured between with bath [Ca
2+] between 6 mM and
60 mM. D, the concentration-effect relationship for both CaSR genotypes shows that wild-type terminals exhibited higher affinity for Ca
2+ (p=0.032).
NSCCcurrentswerenormalizedforeach terminalbymeasuringthedifference betweentheNSCCcurrentandthe60 mMCa
2+-elicitedNSCCcurrentand
dividing thisby the difference betweenthe NSCCcurrents elecited by 6 mM and60 mM Ca
2+. Thecurves representmean6SEMof 7 and6 recordings for
CaSR
+/+ and CaSR
+/2, respectively. The curves were fit to the average data points resulting in Hill coefficients of 0.77 for both genotypes and IC50so f
1.660.2 mM and 1.160.07 mM for CaSR
+/2 and CaSR
+/+, respectively.
doi:10.1371/journal.pone.0008563.g001
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CaSR in heterologous expression systems [38].
Calindol Activation of Terminal CaSR Exhibits Substantial
Delay
We next examined the potency and kinetics of action of
Calindol on the NSCC currents in synaptosomes. Cell-attached
recordings were made from synaptosomes and the membrane
depolarized from 240 to 110 mV every 5 seconds. In the
exemplar recording, the current activated by a 200 ms depolar-
ization briskly and reliably increased to ,6 pA following a
decrease in bath [Ca
2+] (blue line) from 6 mM to 60 mM
(Figure 4A). Addition of Calindol (10 mM), denoted by the green
line, slowly decreased the NSCC current amplitude seen with
60 mMC a
2+ in the bath. Subsequent decreases in Calindol (green
line; range 0.1 to 10 mM) resulted in increases in NSCC current
amplitude at a fixed bath [Ca
2+] (blue line). Like the initial
decrease in response to Calindol, the other changes in NSCC
current amplitude were well described by exponential time
courses. The average IC50 for Calindol was 6.361.1 mMa t
60 mM bath [Ca
2+] (n=4, Figure 4B). The NSCC current
amplitude tended to ‘‘run-up’’ during these prolonged recordings
and consequently the NSCC current amplitudes for the wash (solid
triangle) and the lower doses of Calindol were slightly larger than
the control currents (Figure 4B).
Closer inspection of the NSCC current-time plots (Figure 4C)
shows the kinetics for the Calindol-induced and Ca
2+-induced
reductions in current amplitude were different. The expanded and
superimposed time scales illustrate that the response to Ca
2+ was
much faster than the response to Calindol (Figure 4C). Moreover,
inhibition of the NSCC current by Calindol occurred after a
substantial delay (75 sec) which sharply contrasted with rapid
onset of inhibition of NSCC currents when Ca
2+ was increased
from 60 mM to 6 mM.
Calindol has not previously been reported to exhibit any delay
or latency of action. If Calindol’s action on the [Ca
2+]o-modulated
NSCC signaling pathway in small nerve terminals was mediated
via CaSR we reasoned that this latency should also be present in
measurements using heterologously expressed CaSR. We tested
this idea by studying CaSR modulation in transiently transfected
HEK cells. In this expression system stimulation of CaSR activates
phospholipase C, increasing inositol triphosphate production and
release of Ca
2+ from intracellular stores [39]. Transfected cells
were identified via fluorescence of cotransfected EGFP. Changes
in [Ca
2+]i were measured via the increase in X-rhod1 fluorescence
above baseline (F/F0). Increasing bath [Ca
2+] from 1 to 5 mM (at
t=0) resulted in an average increase in F/F0 of 0.40060.017
(n=12; individual and average responses represented by black and
red traces respectively). After a five minute wash in 1 mM Ca,
application of Calindol (10 mM) resulted in a F/F0 rise of
0.26960.017 in the same 12 cells (Figure 5A). Superimposing
the time courses of effects shows that the response to Calindol
occurs after a substantially larger lag (Figure 5B) than that
observed after activation by Ca
2+. Measurement of the latency (by
deflection .4 S.D. above baseline noise) showed a substantial
increase with Calindol compared to 5 mM Ca
2+ (9.060.2 s vs
23.761.2 s, n=22; p,0.001) in heterologously expressed CaSR
consistent with our observation at isolated small terminals.
Previously, NSCC currents in isolated nerve terminals have
been reported to be insensitive to the weak CaSR agonist NPS-467
[6]. In light of the latency of action of Calindol (Figure 4C) we re-
tested whether NPS-467 was effective on nerve terminals using
longer applications and higher agonist concentrations. Application
of NPS-467 (10 mM) inhibited 3465% (n=4) of the NSCC
Figure 3. Calindol facilitates inhibition of NSCC currents by
extracellular Ca
2+. A, exemplar traces show NSCC currents reversibly
inhibited by addition of Calindol (10 mM) to bath solution. Traces were
recorded in cell-attached mode following 200 ms step depolarization
with 60 mMC a
2+ and 0 Mg
2+ in the bath and 2 mM Ca
2+ and 2 mM
Mg
2+ in the pipette solution (inset). The substantial inhibition of NSCC
current was reversed following washout (gray trace). B, the Ca
2+
concentration-effect relationship was left-shifted by the allosteric CaSR
agonist Calindol (2 mM). These data represent 11 synaptosome
recordings, each normalized to the current observed in 6 mMC a
2+.C ,
average traces show NSCC currents unaffected by the addition of
10 mM Calindol (gray trace) to bath solution containing reduced [Ca
2+]o.
Traces were recorded in cell-attached recording following 200 ms step
depolarization with 0.2 mMC a
2+ and 0 Mg
2+ in the bath and 0.1 mM
Ca
2+ and 0.1 Mg
2+ in the pipette solution (inset). Recordings were less
stable at low divalent concentrations; traces are thus averages of 8
currents elicited with a 5 second duty cycle.
doi:10.1371/journal.pone.0008563.g003
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2+ in cell-attached recordings from
synaptosomes (Figure S2). The high NPS-467 concentration
required is consistent with other reports using expressed CaSR
[40].
CaSR and mGluR1 are both family C GPCRs and although
they only have an amino acid identity ,24% they are similar in
terms of their large extracellular domains, tendency to function
as dimers, and because they both possess a membranous binding
Figure 4. Kinetics and dose-dependence of Calindol inhibtion of NSCC currents in synaptosomes. A, contiguous plot of NSCC current
amplitude versus time showing timecourse of on and off kinetics for Calindol action in a cell-attached synaptosome recording. The outward current
elicited by voltage step (200 ms, 240 to 110 mV) every 5 seconds is plotted against time. NSCC current was reversibly and reliably activated by
reductions in bath [Ca
2+] (0.06–6 mM; blue trace) and inhibited by Calindol (0.1–10 mM; green trace). The Ca
2+ and Calindol axes are logarithmic and
the absence of the green trace indicates Calindol concentration is zero. Calindol (10 mM) inhibited NSCC current after a 1–2 minute delay and
thereafter blocked with mono-exponential time course. The current increased with an exponential time course following reduction of Calindol. B,
Calindol inhibited NSCC currents in bath [Ca
2+]o f6 0mM with an IC50 6.361.1 mM on average (n=4). Each recording was normalized by dividing the
NSCC current amplitude by the NSCC current amplitude elicited by 60 mM bath [Ca
2+] before Calindol was applied. Calindol was generally applied at
higher concentrations first and the amplitude of the NSCC current increased after washout (closed triangle) compared to initial baseline (open circle).
This presumably reflects a run-up phenomenon due to the long duration of these experiments. C, Calindol inhibition of NSCC current is biphasic (i.e.
latency and monoexponential) whereas Ca
2+ inhibition is well described by a single exponential. Two sections of the timecourse data in A displaying
applications of 10 mM Calindol and 6 mM Ca
2+ (just prior to Calindol application) were redrawn on expanded time axis and overlaid so that time zero
corresponded to solution change. Both datasets are well-fit by single exponentials with Calindol decaying significantly more slowly (tau of 73 s for
Calindol vs 6.6 s for Ca
2+) and at a substantial latency.
doi:10.1371/journal.pone.0008563.g004
CaSR Regulates Nerve Terminals
PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8563pocket [35,41]. Since Calindol binds to a membranous pocket
[36], we asked whether the effects of Calindol on synaptosomes
were mediated via mGluR. Using mGluR1-expressing HEK
cells (kind gift of Dr J. Saugstad) we tested if Calindol also
activated mGluR. Bath application of 10 mMg l u t a m a t e
increased F/F0 on average by ,4 (red trace is average of 30
cells each represented by black trace) in the mGluR1 cells
(Figure 6). However, the same cells did not respond to Calindol
(5 mM) when applied 10 minutes later in the presence of 1 mM
[Ca
2+]o. The absence of effect was not due to receptor
desensitization or depletion of Ca
2+ from intracellular stores as
glutamate evoked a similar response when reapplied after an
additional 10 minutes. Untransfected HEK cells did not respond
to glutamate or Calindol (data not shown).
These data strongly support the proposal that the [Ca
2+]o-
modulated NSCC signaling pathway in nerve terminals involves
CaSR. In addition, the distinct kinetics of action for Calindol and
Ca
2+ confirm different mechanisms of action for these two classes
of CaSR agonist.
Nerve Terminal [Ca
2+]o Detector Not Modulated by
Glutamate or GABA
Initially,CaSR,mGluRandGABABR were allpossible candidates
for the neocortical [Ca
2+]o sensor as they are sensitive to [Ca
2+]o
[15,16,17,18] and localized to the synapses of central neurons
[19,20,21,22,23]. Consequently, we addressed if mGluR or GA-
BABR were mediating part of the responseoftheterminalstochanges
in [Ca
2+]o. We addressed this issue by testing whether glutamate or
GABA modulate the NSCC currents in isolated rat neocortical nerve
terminals. In cell-attached recordings, depolarization from 240 to
110 mV activated outward currents through NSCCs that increased
as bath [Ca
2+] was reduced (Figure 7). Co-application of 100 mM
glutamate did not affect the amplitude or rate of activation of the
NSCC currents (Figure 7A, red trace). In addition, glutamate did not
appreciably slow the response of the terminal to changes in [Ca
2+]o
which is illustrated in the plot of NSCC current amplitude versus time
(Figure 7B). The absence of an effect of glutamate was confirmed in
recordings from 11 terminals (Figure 7C).
Brain extracellular glutamate concentration varies between
25 nM at rest [42] and 1–5 mM following exocytosis [43]. While
these higher levels are short-lived and thus less likely to affect
GPCR signaling, we tested whether they could impact the NSCC
current in nerve terminals. Glutamate (2 mM) was ineffective at
altering the size or kinetics of the Ca-modulated currents in rat
terminals (n=5; Figure S3).
We also tested the action of GABA (100 mM) in a parallel set of
experiments (n=3). GABA was equally ineffective at altering current
amplitude, activation or responsiveness to [Ca
2+]o (Figure 7D–F).
The absence of any effect of glutamate or GABA effectively rules out
the mGluR and GABAB receptor as candidate [Ca
2+]o sensors that
modulate NSCC currents in small neocortical terminals.
Discussion
Sustained decreases in [Ca
2+]o will depress subsequent synaptic
transmission due to the exquisite sensitivity of transmitter release
Figure 5. Calindol activation of CaSR expressed in HEK cells
occurred with a greater latency than Ca
2+ activation of CaSR. A,
application of Ca
2+ (5 mM) and Calindol (10 mM) at time zero to CaSR-
expressing HEK cells in 1 mM Ca
2+ and 0 Mg
2+ caused a transient
increase in fluorescence (F) relative to basal level (F0) indicating an
increase in [Ca
2+]i. The black curves denote signal from 12 cells and the
red curves indicate the average. There was a 5 minute delay between
applications. B, average curves from A have been redrawn on the same
time-expanded axis to compare effect latency of Calindol vs. Ca
2+.C ,
histogram of latency of effect for Ca
2+ and Calindol. The latency was
significantly greater for activation by Calindol (23.761.2 s) than by Ca
2+
alone (9.060.2 s) in the recordings from 22 cells (p,0.001).
doi:10.1371/journal.pone.0008563.g005
Figure 6. Glutamate (10 mM) but not Calindol (5 mM) activated
the mGluR1 expressed in HEK cells. Application of glutamate
(horizontal bars) caused a transient increase in fluorescence (F) relative
to basal level (F0) indicating an increase in [Ca
2+]i (left). The black curves
denote signals from 35 cells while red curves indicate averages.
Applications of test solutions were staggered by 10 min to allow for
recovery. Calindol application (horizontal bar) to the same cells did not
produce any change in F/F0 (middle), yet these cells remained
responsive to glutamate (right).
doi:10.1371/journal.pone.0008563.g006
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2+]o [8,44] following its entry via VACC [45,46]. A pathway
that detects such falls in [Ca
2+]o and indirectly activates a voltage-
dependent NSCC was identified in nerve terminals in the
neocortex [6]. Here we described experiments that identify CaSR
as the [Ca
2+]o-sensor in the [Ca
2+]o-sensor-NSCC signaling
pathway in neocortical terminals. Consequently presynaptic CaSR
is positioned to alter presynaptic excitability and attenuate the
impact of falls in [Ca
2+]o on synaptic transmission [28]. In
addition, our experiments led us to two further unexpected
conclusions. First, direct and allosteric CaSR agonists have distinct
kinetics of action. Second, glutamate and GABA do not modulate
the sensitivity of the nerve terminals to changes in [Ca
2+]o
Figure 7. The [Ca
2+]o-modulated NSCC current in rat nerve terminals was unaffected by glutamate and GABA. A, currents activated by
step depolarizations (240 to 110 mV relative to membrane potential) across a range of bath [Ca
2+] (60 mM-6 mM, black traces) superimposed with
those recorded during addition of 100 mM glutamate to the perfusate (red traces). Each trace represents an average of 10–20 currents at steady state
solution conditions from the same cell-attached recording from a synaptosome. B, timecourse of NSCC current amplitude activated by the 200 ms
voltage step every 5 seconds at three [Ca
2+]o (upper trace). Same recording as A. Glutamate application is denoted by horizontal bar. C, normalized
concentration-effect relationship for changes in [Ca
2+]o from NSCC synaptosome recordings is unaffected by glutamate (n=6). Currents represent
NSCC current amplitude at end of voltage step relative to current before step divided by NSCC current amplitude with 60 mMC a
2+ in bath. D, currents
activated by step depolarizations over a range of bath [Ca
2+] (60 mM-6 mM, black traces) superimposed with those recorded during perfusion of
100 mM GABA (red traces). Each trace represents an average of 10–20 currents at steady state solution conditions from the same cell-attached
recording from a synaptosome. E, timecourse of NSCC current amplitude from D at three [Ca
2+]o (upper trace). GABA application is denoted by
horizontal bar. E, normalized concentration-effect relationship for [Ca
2+] o and NSCC amplitude in synaptosome recordings is unaffected by GABA
(n=3). Currents represent NSCC current amplitude at end of voltage step relative to current before step divided by NSCC current amplitude with
60 mMC a
2+ in bath.
doi:10.1371/journal.pone.0008563.g007
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GABABR heterodimers may operate in alternative subcellular
compartments or in other brain regions.
CaSR Is the Nerve Terminal [Ca
2+]o Sensor
We demonstrated that CaSR is present in nerve terminals by
immunoblot and immunofluorescence, that [Ca
2+]o has reduced
potency at terminals from heterozygous mutant CaSR- containing
mice, and that Calindol modulates terminal NSCC currents.
These data strongly support the hypothesis that the mechanism by
which changes in [Ca
2+]o are transduced in neocortical nerve
terminals involves CaSR. Moreover, the lack of any action of
glutamate or GABA on the NSCC current indicate that neither
mGluR nor GABABR act as neocortical nerve terminal [Ca
2+]o-
sensors that regulate the NSCC current.
The [Ca
2+]o-sensor-NSCC signaling pathway was present in the
vast majority of neocortical nerve terminals from mouse (93%) and
rat (79%) consistent with a pervasive role in neuronal signaling.
The IC50 of Ca
2+ inhibition of mouse neocortical terminal NSCC
current (1.1 mM) was lower than the EC50 for Ca
2+ activation of
heterologously expressed CaSR (1.75–4.1 mM) [31,39,47,48].
There are a number of possible explanations for this apparent
difference. First, both sets of measurements detected different
functional changes downstream of CaSR and thus any non-
linearities in the signaling pathways would change the apparent
affinity for Ca
2+. Second, desensitization has also been shown to
alter the CaSR concentration-effect relationship and reduce the
apparent affinity of Ca
2+ [39]. Regulation of CaSR desensitization
is not fully understood [39,49]. However, in our experiments in
nerve terminals, evidence of desensitization was only present in
experiments lasting .30 minutes (Figure 4); NSCC current
amplitudes were generally stable over periods shorter than this
(Figure 7B,E). This contrasted with the relatively transient nature
of the rise of [Ca
2+]i in CaSR expressing HEK cells (Figure 5) and
may in part explain differences in apparent affinities between
preparations. Third, the discrepancies in affinity may arise from
differences between expression systems and native tissue receptors
resulting from post-translational modification or protein-protein
interactions. Consistent with this an increased affinity has been
reported for CaSR signaling in glial cells [50]. The IC50 of [Ca
2+]o
inhibition of terminal NSCC current shifted from 1.1 to 1.6 mM
(Figure 1; CaSR
+/+ and CaSR
+/2 respectively). This modest shift
in affinity is in line with the changes reported following
heterologous co-expression of normal and mutant CaSR [31]
and may be attributed to partial rescue of CaSR mutants by wild-
type receptor (Wang and Smith, unpublished observations). The
small difference in affinity is reflects the mildness of the phenotype
of the heterozygote mouse; the serum ionized calcium levels in
CaSR
+/+ and CaSR
+/2 mice are 1.260.1 and 1.460.0 mM,
respectively [30].
Latency of Calindol Action
Calindol is an allosteric agonist that binds to a relatively
inaccessible membranous pocket on CaSR, increasing the
sensitivity of the receptor to Ca
2+ [36]. The striking difference
between both agonists in the time to onset of action (Figs. 4C,5B)
presumably reflects differences in the mechanism of action of Ca
2+
and Calindol. The much longer latency for Calindol may reflect
the time taken for it to reach and bind to the less accessible
membranous pocket and/or the time taken for CaSR to alter
conformation once Calindol is bound. Inhibition of NSCC
currents by Calindol exhibited a slower exponential rate compared
to when Ca
2+ was applied at 6 mM (Figure 4C). As the bath
[Ca
2+] was 60 mM during the Calindol application, the ten-fold
decrease in the rate of NSCC current block may be postulated to
reflect the reduced rate of Ca
2+ binding to CaSR. However this
explanation is unsatisfactory as Ca
2+-mediated NSCC current
block was more rapid than Calindol-mediated block even when
much lower [Ca
2+]o was employed (Figures 2C & 7B,E). An
alternative explanation is that the second phase (exponential
decline) of NSCC current block by Calindol may in part be
attributed to conformational changes. Further experiments are
required to test these hypotheses. The latency for Calindol was
smaller in CaSR-transfected HEK cells than in synaptosomes and
may reflect differences in the signaling downstream of CaSR.
Heterodimers
CaSR exists as homodimers which form in the endoplasmic
reticulum before transportation to the cell membrane [51].
Heterodimers comprised of CaSR and other GPCRs have also
been identified [27,52]. Howevere these data make it unlikely that
Ca
2+-modulated currents in rat nerve terminals are mediated by
heterodimers composed of CaSR and mGluR or GABABRa s
CaSR-mGluR heterodimers retain sensitivity to glutamate [27].
Our data do not exclude the possibility that CaSR is forming
heterodimers with other GPCRs. GPRC6A, a recently identified
group C GPCR, is one potential candidate that may hetero-
dimerize with CaSR based on similarities in structure and
sensitivity to [Ca
2+]o [53,54].
Function of Nerve Terminal CaSR
CaSR is associated with epilepsy [55] and dementia [56]
however the consequences of CaSR activation in the CNS have
not been fully characterized. In contrast, CaSR has been
intensively studied in the periphery due to its central role in
systemic calcium homeostasis [57]. CaSR activation by external
Ca
2+ regulates parathyroid hormone and calcitonin secretion from
the parathyroid and thyroid glands, respectively, and thus
maintains serum [Ca
2+] [58,59,60]. Brain extracellular [Ca
2+]i s
dynamic and decreases as neuronal activity increases- moderate
decreases in [Ca
2+]o accompany bursts of synaptic activity [61]
while profound falls to ,0.1 mM result from focal brain trauma or
ischemia [62,63]. These falls in [Ca
2+]o will reduce stimulation of
CaSR and thereby increase NSCC activity in the vast majority of
neocortical nerve terminals [28]. Our current model proposes that
decreases in cleft [Ca
2+] will reduce Ca
2+ entry and synaptic
transmission [8] but that the fall in cleft [Ca
2+] will act as feedback
to presynaptic CaSR. Increased NSCC activity may increase
action potential duration [64], prolong Ca
2+ entry at the terminal
and thus increase release probability [65]. Consequently CaSR
may be operating as part of a homeostatic pathway to prevent
synaptic failure when [Ca
2+]o falls [28].
Alterations of such a homeostatic pathway could lead to
increased excitability and gain-of-function CaSR mutations have
been associated with childhood epilepsy [66]. One possible
explanation is that the increased calcium affinity of gain-of-
function CaSR mutants may steepen the response to normal
changes in [Ca
2+]o, lead to overcompensation of the homeostatic
pathway and increase the probability of aberrant activity.
Consistent with this, loss-of-function CaSR2/2 mutant neurons
have a more negative resting membrane potential [28] which
could reduce the likelihood of seizures. However, the CaSR2/2
mutation increases release probability at excitatory synapses at
basal [Ca
2+]o [28] which is expected to increase neuronal
excitability and increase the risk of epilepsy. Clearly additional
study is required to determine how CaSR mutations lead to
epilepsy [55].
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CaSR signaling been overlooked? Previous studies examining
external Ca
2+ on synaptic transmission may have attenuated the
impact of the CaSR-NSCC pathway by using non-physiological
high resting [Ca
2+]o and by increasing bath [Mg
2+] as bath [Ca
2+]
was decreased [8,67,68]. The use of physiological [Ca
2+]o has
unmasked other, previously overlooked signaling pathways that
modulate synaptic transmission [69]. In fact, both recurrent
rhythmic activity and repetitive synaptic transmission in brain
slices more closely resembled findings in vivo when slice [Ca
2+]o
was reduced from the commonly used 2 mM to the more
physiological 1.0–1.2 mM [70,71]. It remains to be determined
how much of the change in neuronal function associated with use
of physiological [Ca
2+]o arises from a reduction in CaSR
activation.
GPCR promiscuity [72,73], the large number of downstream
CaSR signaling pathways [74], and its presence in non-neuronal
brain tissue [50,75] all point to CaSR potentially having additional
actions in the brain. Further experiments are required to elucidate
these other actions.
Conclusions
Decreases in [Ca
2+]o will depress synaptic transmission because
of the exquisite sensitivity of transmitter release to [Ca
2+]o[8,44].
Our experiments identify CaSR as a key component in the
[Ca
2+]o-sensor-NSCC signaling pathway in neocortical terminals
that may alter terminal excitability. The prevalence of CaSR in
neocortex indicates that this signaling pathway may have wide-
ranging influence on synaptic transmission during normal function
and disease states.
Materials and Methods
Synaptosome
All animal procedures were approved by OHSU I.A.C.U.C. in
accordance with the U.S. Public Health Service Policy on
Humane Care and Use of Laboratory Animals and the N.I.H.
Guide for the Care and Use of Laboratory Animals. Male or
female Sprague-Dawley rats or 129S6/SvEv mice (six to eight
weeks old) were deeply anesthetized with isoflurane and
decapitated. As described previously [28], the neocortex was
submerged in ice-cold 320 mM sucrose solution in a Teflon-glass
tissue homogenizer driven at 400–500 RPM, then centrifuged at
3000 g for 3 minutes. The supernatant was centrifuged at 14600 g
for 12 minutes and the upper layer of the resulting pellet
resuspended in approximately 2 ml ice-cold sucrose. Before use
the synaptosomes were washed with Tyrode solution.
Genotyping CaSR Mutant Mice
DNA from mouse tail samples was released by treatment with
50 mM NaOH at 95uC for 15 minutes, followed by the addition of
1 M Tris buffer, pH 8.0, containing 10 mM EDTA. Polymerase
chain reaction was then performed using DNA solution and three
primers: CaSR 59: TCTCTTCTCTTTAGGTCCTGAAAGA,
CaSR 39: TCATTGATGAACAGTCTTTCTCCCT, and r-
neo2: TCTTGATTCCCACTTTG TCCT TG TA. The samples
wererun ona 1%agarose gelandthe sampleidentified asCaSR
+/+,
CaSR
+/2, or CaSR
2/2.
HEK Cell Culture and Transient Transfection
HEK 293 cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 5% fetal bovine serum (FBS). For
intracellular [Ca
2+] ([Ca
2+]i) imaging experiments, ,10
5 HEK
cells were plated in 500 ml medium onto poly-D-lysine-coated glass
coverslips in 24-well plate. Cells were transfected with pEGFP/
CaSR plasmid DNA using Lipofectamine one day after plating.
Briefly, 0.8 mg pEGFP/CaSR plasmid DNA was mixed in 50 ml
Opti-MEMH I Reduced Serum Medium and 10 ml Lipofectamine
2000 (Invitrogen) mixed in 50 ml Opti-MEMH I Reduced Serum
Medium. The mixtures were incubated for 20 minutes and then
added to each well containing cells and medium. The transfection
medium was replaced with DMEM containing 5% FBS, six hours
later. Cells were kept in culture for another 18 to 24 hours before
use. Untransfected cells were used in control experiments 42–
48 hours after plating. Stable lines of HEK cells containing
mGluR1 were used once confluent.
Immunofluorescence
Synaptosomes were fixed for 30 minutes at 4uC with 4%
formaldehyde, washed with PBS, and then placed in blocking
solution containing 2% goat serum, 1% BSA and 0.4% saponin
for 30 mins at 25uC. Overnight incubation in primary antibody-
containing solution (4641, polyclonal antibody kindly provided by
Dr E. Nemeth of NPS Pharmaceuticals [31] or a monoclonal
antibody against synaptophysin, MAB5258 Chemicon) at 4uC was
followed by a wash and then 30 minute incubation with secondary
antibodies at 37uC. Coverslips were then washed and mounted,
together with a quenching agent (Citifluor), and viewed by
fluorescence microscopy.
Western Blots
Brains were harvested, flash frozen, and homogenized in a
protease inhibitor-containing lysis buffer (10 mg/mL aprotinin,
10 mg/mL pepstatin A, 10 mg/mL leupeptin, 10 mg/mL benza-
midine, and 1 mM PMSF) on ice. Protein concentration was
determined by the Bradford technique. Membrane fragments were
run on a 7% polyacrylamide gel and then transferred overnight.
Blots were blocked with 3% albumin and then stained with a
polyclonal anti-CaSR antibody [76] at 1 in 1000 dilution (kindly
provided by Dr K Rodland) and with secondary antibodies
conjugated with horseradish peroxidase at 1 in 50,000. In control
experiments the primary antibody was preincubated with 50 mg/
mL blocking peptide. Bands were visualized with chemilumines-
cence.
Electrophysiology
Recordings were made from acutely isolated single nerve
terminals (synaptosomes) visualized using an inverted microscope
(IX70, Olympus) as previously described [6]. Electrodes with
resistances of 15–40 MV were used to make cell-attached
recordings from terminals. Test solutions were continuously
applied from a nearby capillary tube and manifold at 1–3 ml/
min (23–25uC). We employed a Tyrode solution (in mM; 150
NaCl, 4 KCl, 2 CaCl2, 2 MgCl2 10 HEPES, and 10 glucose, at
pH 7.35 with NaOH) in the bath and electrode unless otherwise
stated. In the mouse synaptosome experiments, when [Ca
2+] was
greater than 0.6 mM, NaCl was decreased isotonically for CaCl2.
Voltage-clamp recordings were obtained using Pulse software and
an EPC- amplifier 9 (Heka Instruments Inc, MA). Leak currents
were subtracted with a p/-4 protocol. Currents were prefiltered
with a 2 or 5 kHz Bessel filter and digitized at 20–100 ms per
point. Calindol stock solution was made up at 10 mM in ethanol
and stored as aliquots at 220uC.
Measurement of [Ca
2+]i Response
[Ca
2+]i was measured in HEK cells transfected with CaSR-
EGFP or mGluR1 using the fluorescent indicators, X-rhod-1 or
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with 2 mM AM X-rhod-1 or 5 mM AM Fluo-4 in Tyrode solution,
and then placed on the stage of an inverted microscope (IX-70,
Olympus). Images were acquired using a 1.2 N.A. 63x water
immersion or PlanApo 1.42 N.A. 60x oil-immersion objective and
cooled CCD camera (Orca-ER, Hamamatsu) with computer
controlled shutter (UNIBLITZ VMM-D1, Vincent Associates,
Rochester, NY). Fluorophores were excited with a halogen lamp.
Fluo-4 was excited at 470–490 nm and fluorescence emission
measured via a LP filter 510 nm while X-rhod-1 was excited at
542–582 nm and emission measured at 604–644 nm (TXRED-
4040B-OMF-ZERO, Semrock, NY). Images were captured and
processed using Wasabi image software. The changes in [Ca
2+]i
are reported as fluorescence ratios (F/F0) where F0 represents the
baseline fluorescence. About 10–20 cells with similar cell surface
GFP fluorescence from a single field were analyzed simultaneously
using Wasabi software.
Data Analysis
Data were analyzed using custom macros written in Igor Pro
(Wavemetrics, Lake Oswego, OR). As previously dose-response
data were fit with the Hill equation where I represented current at
concentration A of agonist and Imax was the maximum current
and n represented the Hill coefficient [77]. NSCC current
amplitudes were measured over the last 2–5 ms of a 200 ms
depolarizing step. In synaptosome recordings, latency or delay of
action of Calindol was measured from the plot of NSCC current
amplitude versus time (diary plot) using the interception of the line
representing average NSCC current amplitude at 60 mMC a
2+
and the extrapolated exponential fitted to the NSCC current
during inhibition by Calindol (see Figure 4C). The delay equaled
the difference between the intercept and the time at which
solutions were switched (t=0). In experiments using HEK cells the
responses were not described by single exponentials and so a
different approach was taken. The standard deviation of F0 was
measured and latency was defined as the time between solution
change and the point at which F/F0 first deviated above F0 by
more than four standard deviations.
Tests for paired or unpaired replicates were used as appropriate.
Mean6S.E.M. values are reported in general. In the case of
nonparametric data, the Mann-Whitney test was used. All tests
were two-tailed and a p value,0.05 was considered significant.
Graphpad Prism software was used to calculate p-values.
Supporting Information
Figure S1 NSCC current amplitudes were unaffected by
ethanol. Plot of average normalized NSCC amplitude evoked by
depolarizing steps (240 to 110 mV for 200 ms) in the presence of
60 mM bath Ca
2+ from four recordings. Application of ethanol at
0.1% (black horizontal bar) was associated with a small (,10%),
transient (,20 ms) decrease in NSCC current amplitude. At 200
seconds there was no detectable change in the NSCC.
Found at: doi:10.1371/journal.pone.0008563.s001 (0.12 MB EPS)
Figure S2 NPS-467 reversibly inhibits NSCC currents in nerve
terminal recordings. NSCC currents activated by step depolariza-
tions (240 to 110 mV relative to membrane potential) in the
presence of 60 mM [Ca
2+]o were decreased by co-application of
10 mM NPS-467. Each trace represents an average of 10–20
currents at steady state solution conditions from the same
synaptosome-attached recording. Timecourse of NSCC current
amplitude from the same recording at three [Ca
2+]o (upper trace)
revealed that NPS reversibly inhibited the NSCC current
amplitude.
Found at: doi:10.1371/journal.pone.0008563.s002 (0.28 MB EPS)
Figure S3 The [Ca
2+]o-modulated NSCC current in rat nerve
terminals was unaffected by 2 mM glutamate. NSCC currents
activated by step depolarizations (240 to 110 mV relative to
membrane potential) over a range of bath [Ca
2+]o (60 mM-6 mM,
black traces) superimposed with those recorded in the presence of
2 mM glutamate (red traces). Each trace represents average of 10–
20 currents at steady state solution conditions from the same
synaptosome-attached recording.
Found at: doi:10.1371/journal.pone.0008563.s003 (0.44 MB EPS)
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